Cancer-Induced Depression

There is a strong correlation between physical illnesses and mood disorders. This relationship is particularly robust for cancer and depression; cancer patients carry a 50% risk of major depression. Clinically-speaking, cancer-associated depression is not a psychiatric issue of secondary importance: depression is associated with decreased cancer survivorship, and depressed cancer patients are three times more likely to be noncompliant with treatment protocols. Surprisingly, however, causal links between chronic peripheral diseases, such as cancer, and emotional disturbances have not been established, and have remained largely uninvestigated.
A number of chemical messengers in the body are capable of inducing depressive-like states; these signaling molecules include neurotransmitters, hormones, and cytokines. Cytokines are signaling molecules produced by cells in the immune system, but they are also secreted in into the general circulation by some types of tumors. The proposed work uses a rodent model of breast cancer to examine whether tumor-derived cytokines cause depression. Experiments will test whether tumor-derived cytokines gain access to the brain, and if so, whether they trigger changes in neural systems that regulate emotion (the limbic system) that ultimately lead to a depressive-like syndrome.
Additional experiments will examine whether cancer suppresses the activity of the endocrine stress-response system (the hypothalamic-pituitary-adrenal axis) which normally functions to inhibit cytokine signaling in the brain, thereby resulting in an amplification of the depression-inducing effects of even modest increases in cytokines. Establishing a role for cytokines or stress hormones in cancer-induced depression would have implications for cancer treatment, informing the development of therapies that target specific receptors to alleviate cancer-induced mood disorders. The work also stands to generate novel insights into immune-to-brain signaling which will increase our basic understanding of how chronic diseases affect emotions.

Other Grants

Sarah C. Goetz, Ph.D., Duke University
Uncovering a Novel Role for Primary Cilia in Eph/Ephrin Signaling in Neurons
2022 Seed GrantSarah C. Goetz, Ph.D. Duke University Women’s Council Seed Grant Primary cilia are tiny projections from cells that function like an antenna- they receive and may also send…
Erin M. Gibson, Ph.D., Stanford University
Circadian Regulation of Oligodendroglial Senescence and Metabolomics in Aging
2022 Seed GrantErin M. Gibson, Ph.D.Stanford University The brain consists of two main classes of cells, neurons and glia. Glia make-up more than half of the cells in the brain…
Yvette Fisher, Ph.D., University of California, Berkeley
Dynamic Modulation of Synaptic Plasticity During Spatial Exploration
2022 Seed GrantYvette Fisher, Ph.D.University of California, Berkeley The Virginia (Ginny) & Roger Carlson Seed Grant Cognitive flexibility is critical for appropriately adjusting thoughts and behaviors to meet changing demands…
Byoung Il Bae, Ph.D., University of Connecticut
Unique Vulnerability of Developing Human Cerebral Cortex to Loss of Centrosomal Protein
2022 Seed GrantByoung Il Bae, Ph.D.University of Connecticut Carl & Marilynn Thoma Foundation Seed Grant The cerebral cortex is the largest and outermost part of the human brain. It is…